CAJ | 학술논문

目的探讨缬沙坦联合氨氯地平治疗原发性高血压的成本和效果.方法选择2010年7月-2012年3月共78例门诊原发性高血压患者为研究对象,按照随机抽取方式分为两组,对照组给予氨氯地平治疗,实验组给予缬沙坦联合氨氯地平治疗,对比两组的成本和效果.结果实验组患者的总有效率显著高于对照组,P<0.05;不良反应比较无显著差异,P>0.05;实验组成本-效果数值显著低于对照组,P<0.05.结论采用缬沙坦联合氨氯地平治疗原发性高血压不但有较好的治疗效果且经济,普及性高,值得应用.
목적탐토힐사탄연합안록지평치료원발성고혈압적성본화효과.방법선택2010년7월-2012년3월공78례문진원발성고혈압환자위연구대상,안조수궤추취방식분위량조,대조조급여안록지평치료,실험조급여힐사탄연합안록지평치료,대비량조적성본화효과.결과실험조환자적총유효솔현저고우대조조,P<0.05;불량반응비교무현저차이,P>0.05;실험조성본-효과수치현저저우대조조,P<0.05.결론채용힐사탄연합안록지평치료원발성고혈압불단유교호적치료효과차경제,보급성고,치득응용.
Objective To study the cost-effectiveness of valsartan combined amlodipine treatment of essential hypertension. Methods From July 2010 to March 2012,a total of 78 columns of outpatients with hypertension as the research object, according to randomly divided into two groups, the control group was given amlodipine treatment, the experimental group were given valsartan combined amlodipine treatment, the cost of the two groups were compared-effect. Results Joint group of patients with total efficiency higher than that in control group (P<0.05);adverse reactions was no significant difference, P>0.05;The combined group of cost-effectiveness value is lower than the control group, P<0.05. Conclusion The combination of valsartan and amlodipine in treatment of essential hypertension not only has good treatment effect and economy, high universality, it is worthy of application.